Negm, Essamedin M.
Ali, Hossam Tharwat https://orcid.org/0000-0001-8077-5911
Nofal, Hanaa A.
Mosallem, Ahmed
Ahmed, Ashraf Elsayed
Morsy, Ahmed Ali
Elserafy, Tamer S.
Elgohary, Marwan
Altaher, Khaled Mohamed
Sharaf EL Deen, Sherif
Albialy, Hani A.
Gouda, Ahmed M.
Beniamen, Ahmed
Funding for this research was provided by:
South Valley University
Article History
Received: 13 January 2025
Accepted: 22 May 2025
First Online: 18 June 2025
Change Date: 10 September 2025
Change Type: Update
Change Details: The original article has been updated to correct Ahmed M. Gouda’s affiliation and to update the ketamine infusion dosage from (0.3 μg/kg/hr) to (0.3 mg/kg/hr)..
Change Date: 22 September 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s12028-025-02373-3
Declarations
:
: The authors declare no competing interests.
: Our study was approved by the research ethical committee of the Faculty of Medicine, Zagazig University with the reference number ZU-IRB#:6928–6-9–2021, and it was registered at clinicaltrials.gov (NCT05149586) and conducted per the revised declaration of Helsinki. Before enrollment, as patients could not decide to participate in this study, written informed consent was obtained from first-degree relatives of all participants.
: ClinicalTrials.gov: NCT05149586.